{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:14:00Z","timestamp":1793834040220,"version":"4.6.1"},"reference-count":36,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Background: Limited data exist on primary palatine tonsil Non-Hodgkin lymphoma (NHL) from regions with constrained healthcare access. This study investigated this malignancy in Western and South-Western Romania, comparing lower-stage (Ann-Arbor I-III) and advanced-stage (IV) disease. Methods: A retrospective cohort study (2010\u20132019) at a tertiary referral hospital included 59 patients with primary palatine tonsil NHL. Data on demographics, clinical presentation, comorbidities (including viral hepatitis B\/C), histology, International Prognostic Index (IPI) score, treatment, and outcomes were collected. Statistical comparisons between lower-stage (n = 26) and advanced-stage (n = 33) groups were performed. Results: A high proportion presented with advanced-stage disease (55.9%). The advanced-stage group had significantly more B symptoms (90.9% vs. 69.2%, p = 0.038) and elevated LDH levels (93.9% vs. 57.7%, p = 0.013). Viral hepatitis B and\/or C infection was more frequent in advanced-stage disease (30.3% vs. 15.4%, p = 0.44). Combined chemoradiotherapy was more commonly used in lower-stage disease (38.46% vs. 12.12%, p = 0.019). There was no statistically significant difference in relapse rates between the groups. Conclusions: This study highlights the substantial burden of advanced-stage primary palatine tonsil NHL in Western Romania, suggesting a need for improved early detection. The association between viral hepatitis and advanced-stage, although not statistically significant, warrants further investigation. These findings may inform tailored management approaches in resource-constrained settings.<\/jats:p>","DOI":"10.3390\/hematolrep17020017","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T03:35:28Z","timestamp":1743132928000},"page":"17","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary Palatine Tonsil Non-Hodgkin Lymphoma in Western Romania: A Comparison of Lower-Stage and Advanced-Stage Disease"],"prefix":"10.3390","volume":"17","author":[{"given":"Raluca","family":"Morar","sequence":"first","affiliation":[{"name":"Doctoral School, Department of General Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0320-6904","authenticated-orcid":false,"given":"Norberth-Istvan","family":"Varga","sequence":"additional","affiliation":[{"name":"Doctoral School, Department of General Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7210-1263","authenticated-orcid":false,"given":"Delia Ioana","family":"Horhat","sequence":"additional","affiliation":[{"name":"ENT Department, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ion Cristian","family":"Mot","sequence":"additional","affiliation":[{"name":"ENT Department, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-4608","authenticated-orcid":false,"given":"Nicolae Constantin","family":"Balica","sequence":"additional","affiliation":[{"name":"ENT Department, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina-Andree","family":"Tischer","sequence":"additional","affiliation":[{"name":"ENT Department, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Susan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Centre for Preventive Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3531-3974","authenticated-orcid":false,"given":"Razvan","family":"Susan","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Centre for Preventive Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8001-7672","authenticated-orcid":false,"given":"Diana Luisa","family":"Lighezan","sequence":"additional","affiliation":[{"name":"Multidisciplinary Research Center for Malignant Hematological Diseases, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodica Anamaria","family":"Negrean","sequence":"additional","affiliation":[{"name":"Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.pop.2016.07.012","article-title":"Lymphoma","volume":"43","author":"Mugnaini","year":"2016","journal-title":"Prim. Care"},{"key":"ref_2","first-page":"34","article-title":"Lymphoma: Diagnosis and Treatment","volume":"101","author":"Lewis","year":"2020","journal-title":"Am. Fam. Physician"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1024\/0040-5930\/a000088","article-title":"Management of non-Hodgkin lymphomas arising at extranodal sites","volume":"67","author":"Zucca","year":"2010","journal-title":"Ther. Umsch."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1052-5149(03)00039-X","article-title":"Hodgkin and non-Hodgkin lymphoma of the head and neck: Clinical, pathologic, and imaging evaluation","volume":"13","author":"Weber","year":"2003","journal-title":"Neuroimaging Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4103\/jfmpc.jfmpc_1037_19","article-title":"Non-Hodgkin\u2019s lymphoma: A review","volume":"9","author":"Singh","year":"2020","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.4103\/jcrt.JCRT_213_20","article-title":"Lymphomas of the head-and-neck region","volume":"17","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2214\/ajr.149.3.575","article-title":"Lymphomas of the head and neck: CT findings at initial presentation","volume":"149","author":"Lee","year":"1987","journal-title":"Am. J. Roentgenol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2214\/ajr.149.4.785","article-title":"Non-Hodgkin\u2019s lymphoma of the head and neck: CT evaluation of nodal and extranodal sites","volume":"149","author":"Harnsberger","year":"1987","journal-title":"Am. J. Roentgenol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13005-018-0186-0","article-title":"Clinical presentation and characteristics of lymphoma in the head and neck region","volume":"15","author":"Storck","year":"2019","journal-title":"Head Face Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.5732\/cjc.009.10524","article-title":"Computed tomography features of enlarged tonsils as a first symptom of non-Hodgkin\u2019s lymphoma","volume":"29","author":"Wang","year":"2010","journal-title":"Chin. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00277-010-0970-9","article-title":"Primary tonsillar lymphomas according to the new World Health Organization classification: To report 87 cases and literature review and analysis","volume":"89","author":"Mohammadianpanah","year":"2010","journal-title":"Ann. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00277-004-0860-0","article-title":"Treatment results of tonsillar lymphoma: A 10-year experience","volume":"84","author":"Mohammadianpanah","year":"2005","journal-title":"Ann. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.2019002729","article-title":"International prognostic indices in diffuse large B-cell lymphoma: A comparison of IPI, R-IPI, and NCCN-IPI","volume":"135","author":"Ruppert","year":"2020","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mu, S., Shi, D., Ai, L., Fan, F., Peng, F., Sun, C., and Hu, Y. (2021). International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.732006"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1023\/A:1008205619617","article-title":"Effect of age on the characteristics and clinical behavior of non-Hodgkin\u2019s lymphoma patients. The Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"8","author":"Anderson","year":"1997","journal-title":"Ann. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.1988.6.12.1838","article-title":"The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin\u2019s lymphoma","volume":"6","author":"Vose","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Thandra, K.C., Barsouk, A., Saginala, K., Padala, S.A., Barsouk, A., and Rawla, P. (2021). Epidemiology of Non-Hodgkin\u2019s Lymphoma. Med. Sci., 9.","DOI":"10.3390\/medsci9010005"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/jnci\/djac030","article-title":"Rural-Urban Disparities in Cancer Outcomes: Opportunities for Future Research","volume":"114","author":"Bhatia","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4143\/crt.2001.33.4.324","article-title":"Clinical Prognostic Factors and Treatment Outcome of Aggressive Non-Hodgkin\u2019s Lymphoma in Elderly Patients","volume":"33","author":"Choi","year":"2001","journal-title":"Cancer Res. Treat."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Qi, J., Gu, C., Wang, W., Xiang, M., Chen, X., and Fu, J. (2021). Elevated Lactate Dehydrogenase Levels Display a Poor Prognostic Factor for Non-Hodgkin\u2019s Lymphoma in Intensive Care Unit: An Analysis of the MIMIC-III Database Combined with External Validation. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.753712"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","author":"Shipp","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bjc.1993.509","article-title":"Serum lactate dehydrogenase level as a prognostic factor in Hodgkin\u2019s disease","volume":"68","author":"Caballero","year":"1993","journal-title":"Br. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V86.4.1460.bloodjournal8641460","article-title":"International Prognostic Index for aggressive non-Hodgkin\u2019s lymphoma is valid for all malignancy grades","volume":"86","author":"Hermans","year":"1995","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000011886","article-title":"Diffuse large cell lymphomas: Identification of prognostic factors and validation of the International Non-Hodgkin\u2019s Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study","volume":"55","author":"Nicolaides","year":"1998","journal-title":"Oncology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15403\/jgld.2014.1121.251.hbc","article-title":"A Seroprevalence Study of Hepatitis B and C Virus Infections in a Hospitalized Population in Romania, an Opportunity for a Better National Prevention and Control Strategy","volume":"25","author":"Popovici","year":"2016","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5501\/wjv.v1.i6.162","article-title":"Hepatitis viruses and non-Hodgkin\u2019s lymphoma: A review","volume":"1","author":"Datta","year":"2012","journal-title":"World J. Virol."},{"key":"ref_27","first-page":"1256","article-title":"Hepatitis Virus-associated Non-hodgkin Lymphoma: Pathogenesis and Treatment Strategies","volume":"11","author":"Zhang","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","article-title":"Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management","volume":"59","author":"Arcaini","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/10428199609051728","article-title":"Hepatitis C virus and non-Hodgkin\u2019s lymphomas","volume":"22","author":"Pozzato","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/jmv.25653","article-title":"Hepatitis virus B and C infections are associated with an increased risk of non-Hodgkin lymphoma: A nested case-control study using a national sample cohort","volume":"92","author":"Kim","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood-2010-06-275818","article-title":"Hepatitis viruses and non-Hodgkin lymphoma: Epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities","volume":"117","author":"Marcucci","year":"2011","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1614598","article-title":"Obinutuzumab for the First-Line Treatment of Follicular Lymphoma","volume":"377","author":"Marcus","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3324\/haematol.2016.152272","article-title":"Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma","volume":"102","author":"Grigg","year":"2017","journal-title":"Haematologica"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2013-01-481341","article-title":"Obinutuzumab (GA101) plus CHOP or FC in relapsed\/refractory follicular lymphoma: Results of the GAUDI study (BO21000)","volume":"122","author":"Radford","year":"2013","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","article-title":"International Lymphoma Radiation Oncology Group. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"89","author":"Illidge","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/PPO.0000000000000453","article-title":"Radiotherapy for Non-Hodgkin Lymphomas","volume":"26","author":"Imber","year":"2020","journal-title":"Cancer J."}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/17\/2\/17\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:03:57Z","timestamp":1760029437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/17\/2\/17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["hematolrep17020017"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep17020017","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}